Pharmacokinetics of Two Formulation of Tenofovir Disoproxil Fumarate

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 22, 2019

Primary Completion Date

May 9, 2020

Study Completion Date

August 31, 2020

Conditions

Pharmacokinetic of Tenofovir in Healthy Subjects

Interventions

DRUG

Tenofovir Disoproxil Fumarate 300 MG

One tablet of Viproof Film Coated Tablets or Viread Tablets will be orally administrated with 240 mL of water in the morning.

Trial Locations (1)

Taichung Veterans General Hospital, Taichung

All Listed Sponsors

collaborator

Taichung Veterans General Hospital

OTHER

lead

Yung Shin Pharm. Ind. Co., Ltd.

INDUSTRY

NCT04671563 - Pharmacokinetics of Two Formulation of Tenofovir Disoproxil Fumarate | Biotech Hunter | Biotech Hunter